Cortney Caudill
Geschäftsführer bei HALOZYME THERAPEUTICS, INC.
Aktive Positionen von Cortney Caudill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Geschäftsführer | - | - |
Karriereverlauf von Cortney Caudill
Ehemalige bekannte Positionen von Cortney Caudill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 | 06.01.2023 |
| Corporate Officer/Principal | 06.01.2023 | 01.10.2023 | |
| Baxalta Schweiz AG | Corporate Officer/Principal | 01.04.2014 | 01.02.2016 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
| SAMSUNG BIOLOGICS CO.,LTD. | Corporate Officer/Principal | 01.02.2012 | - |
Ausbildung von Cortney Caudill
| Fordham University | Masters Business Admin |
| The University of Texas at Austin | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Südkorea | 2 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| SAMSUNG BIOLOGICS CO.,LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
| Baxalta Schweiz AG |
- Börse
- Insiders
- Cortney Caudill
- Erfahrung